LL-37 / working resource
Primary source desk
Keep the original documents and the limits of their conclusions within reach.
Start with the product-specific question
Cathelicidin and innate immunity
Antimicrobial mechanism separated from treatment claims. What should I know about cathelicidin and innate immunity?
Open the LL-37 library ↗The early randomized study enrolled 34 people and investigated topical LL37 for venous leg ulcers over a four-week treatment period.
Read the original record ↗
The original record comes first.
These are starting points for the LL-37 library. Read the source's exact question, product, population and date. A source can be authoritative for one claim and irrelevant to another.
Keep claims and sources together.
The early randomized study enrolled 34 people and investigated topical LL37 for venous leg ulcers over a four-week treatment period.
Supporting record ↗Some lower-concentration groups improved healing predictors; the highest-concentration group did not differ from placebo.
Supporting record ↗HEAL LL-37 randomized149 participants;148 were treated and144 entered the full efficacy-analysis set. It compared topical LL-37 plus compression with placebo plus compression.
Supporting record ↗The phaseIIb full-cohort analysis did not find a significant healing improvement with LL37.
Supporting record ↗These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.